Long-term follow up of patients with common variable immunodeficiency treated with intravenous immunoglobulin: Reevaluation of intravenous immunoglobulin replacement therapy
- 1 June 1993
- journal article
- Published by Springer Nature in Biotherapy
- Vol. 7 (2), 101-107
- https://doi.org/10.1007/bf01877733
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Safety Aspects of Intravenous ImmunoglobulinsImmunological Investigations, 1988
- HIGH-DOSE VERSUS LOW-DOSE INTRAVENOUS IMMUNOGLOBULIN IN HYPOGAMMAGLOBULINAEMIA AND CHRONIC LUNG DISEASEThe Lancet, 1987
- A Comparison of Native and Modified Intravenous Immunoglobulin for the Management of HypogammaglobulinemiaThe Lancet Healthy Longevity, 1987
- NON-A, NON-B HEPATITIS AFTER INTRAVENOUS GAMMAGLOBULINThe Lancet, 1986
- Inactivation and partition of human T‐cell lymphotrophic virus, type III, during ethanol fractionation of plasmaTransfusion, 1986
- NON-A, NON-B HEPATITIS AND INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1985
- NON-A, NON-B HEPATITIS OCCURRING IN AGAMMAGLOBULINAEMIC PATIENTS AFTER INTRAVENOUS IMMUNOGLOBULINThe Lancet, 1984
- Use of a new chemically modified intravenous IgG preparation in severe primary humoral immunodeficiency: Clinical efficacy and attempts to individualize dosageClinical Immunology and Immunopathology, 1984
- Use of intravenous γ-globulin in antibody immunodeficiency: Results of a multicenter controlled trialClinical Immunology and Immunopathology, 1982
- Clinical Effect and Metabolism of S‐Sulfonated Immunoglobulin in 7 Patients with Congenital Humoral ImmunodeficiencyVox Sanguinis, 1979